$PBIO Pressure BioSciences, Inc. Reports Record F
Post# of 1354
Pressure BioSciences, Inc. Reports Record Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update
Q4 2018 Total Revenue Increases 37% over Q4 2017, Setting New Record Quarterly High;
FY 2018 Total Revenue Increases 10% over FY 2017, Setting New Record Annual High;
Initial Revenue Reported from New BioPharma Services and UST Businesses;
Balance Sheet Improves with Significant Conversion of Debt to Equity.
Investor Conference Call Scheduled for Thursday, April 25, 2019 at 4:30 PM EDT
https://www.otcmarkets.com/stock/PBIO/news/Pr...?id=225978